Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 177651-177700 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT02021045
Cerebral Microembolism During Hemodialysis
N/A
Completed
40 participants
Started: Sep 30, 2013 · Completed: Mar 31, 2016
3 conditions
1 sponsor
1 location
NCT01856907
Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
PHASE4
Completed
36 participants
Started: Sep 28, 2013 · Completed: Sep 28, 2017
1 condition
2 sponsors
1 location
NCT01990742
Improving Palliative Care Through Teamwork
NA
Completed
31 participants
Started: Sep 27, 2013 · Completed: Apr 1, 2017
1 condition
2 sponsors
1 location
NCT01915602
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
PHASE2
Completed
14 participants
Started: Sep 27, 2013 · Completed: Feb 8, 2017
1 condition
1 sponsor
79 locations
NCT01942174
VACcination In Methotrexate Treated Rheumatoid Arthritis Patients
PHASE3
Completed
276 participants
Started: Sep 27, 2013 · Completed: Jul 10, 2019
1 condition
3 sponsors
21 locations
NCT01939366
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
PHASE2
Completed
699 participants
Started: Sep 27, 2013 · Completed: Jan 28, 2015
3 conditions
1 sponsor
82 locations
NCT02860585
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
N/A
Completed
235 participants
Started: Sep 27, 2013 · Completed: Feb 29, 2016
1 condition
1 sponsor
1 location
NCT01985126
An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD
PHASE2
Completed
124 participants
Started: Sep 27, 2013 · Completed: May 30, 2017
1 condition
1 sponsor
23 locations
NCT01950273
Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma
PHASE1
Completed
95 participants
Started: Sep 27, 2013 · Completed: Dec 22, 2015
1 condition
1 sponsor
29 locations
NCT01925209
Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
PHASE2/PHASE3
Completed
251 participants
Started: Sep 26, 2013 · Completed: Jan 6, 2016
1 condition
1 sponsor
38 locations
NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
PHASE3
Completed
521 participants
Started: Sep 26, 2013 · Completed: Sep 28, 2022
1 condition
2 sponsors
247 locations
NCT01892566
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
NA
Completed
133 participants
Started: Sep 26, 2013 · Completed: May 9, 2022
2 conditions
2 sponsors
1 location
NCT01908816
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
PHASE3
Completed
270 participants
Started: Sep 26, 2013 · Completed: Jan 8, 2016
4 conditions
1 sponsor
39 locations
NCT01959815
Novel Screening Strategies for Scleroderma PAH
N/A
Completed
156 participants
Started: Sep 26, 2013 · Completed: Nov 6, 2019
2 conditions
1 sponsor
1 location
NCT01938638
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
PHASE1
Completed
80 participants
Started: Sep 26, 2013 · Completed: Sep 19, 2016
1 condition
1 sponsor
12 locations
NCT01881230
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
PHASE2/PHASE3
Completed
191 participants
Started: Sep 26, 2013 · Completed: Oct 28, 2016
11 conditions
1 sponsor
140 locations
NCT01915212
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
PHASE1
Completed
69 participants
Started: Sep 26, 2013 · Completed: Mar 6, 2017
1 condition
2 sponsors
1 location
NCT01908426
Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib
PHASE3
Completed
707 participants
Started: Sep 26, 2013 · Completed: Jan 12, 2021
1 condition
1 sponsor
104 locations
NCT01930214
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
N/A
Completed
350 participants
Started: Sep 26, 2013 · Completed: Jun 1, 2017
1 condition
1 sponsor
34 locations
NCT04429802
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
NA
Completed
17 participants
Started: Sep 26, 2013 · Completed: Oct 3, 2016
2 conditions
1 sponsor
0 locations
NCT01809288
Identifying Risk for Diabetes and Heart Disease in Women
N/A
Completed
146 participants
Started: Sep 26, 2013
4 conditions
1 sponsor
1 location
NCT03298776
I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions
NA
Completed
758 participants
Started: Sep 26, 2013 · Completed: Jan 5, 2019
1 condition
1 sponsor
1 location
NCT03644134
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
NA
Completed
51 participants
Started: Sep 26, 2013 · Completed: Jul 14, 2015
1 condition
1 sponsor
0 locations
NCT02837965
Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
N/A
Completed
149 participants
Started: Sep 26, 2013 · Completed: Dec 31, 2018
1 condition
1 sponsor
1 location
NCT02225470
Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
PHASE3
Completed
530 participants
Started: Sep 26, 2013 · Completed: Jun 22, 2018
5 conditions
1 sponsor
35 locations
NCT01934205
To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944
PHASE1
Completed
22 participants
Started: Sep 25, 2013 · Completed: Dec 21, 2013
1 condition
1 sponsor
1 location
NCT01977144
Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency
NA
Completed
206 participants
Started: Sep 25, 2013 · Completed: Jan 1, 2020
1 condition
1 sponsor
1 location
NCT01895777
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
PHASE3
Completed
267 participants
Started: Sep 25, 2013 · Completed: Nov 14, 2019
1 condition
1 sponsor
65 locations
NCT01981954
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
PHASE3
Completed
23 participants
Started: Sep 25, 2013 · Completed: Dec 18, 2015
2 conditions
1 sponsor
8 locations
NCT02855775
Monoclonal Antibodies Elimination in Breast Cancer Patient
NA
Completed
76 participants
Started: Sep 25, 2013 · Completed: Oct 15, 2020
1 condition
1 sponsor
1 location
NCT01687218
Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
PHASE2
Completed
195 participants
Started: Sep 25, 2013 · Completed: May 26, 2015
1 condition
4 sponsors
8 locations
NCT01949090
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older
PHASE2
Completed
363 participants
Started: Sep 25, 2013 · Completed: Oct 23, 2014
1 condition
1 sponsor
8 locations
NCT02319330
Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women
NA
Completed
120 participants
Started: Sep 25, 2013 · Completed: Jul 31, 2017
2 conditions
3 sponsors
1 location
NCT01888432
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
PHASE3
Completed
285 participants
Started: Sep 25, 2013 · Completed: Apr 21, 2018
1 condition
1 sponsor
42 locations
NCT01977651
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
PHASE4
Completed
424 participants
Started: Sep 25, 2013 · Completed: Jan 11, 2019
1 condition
2 sponsors
76 locations
NCT05657522
Early Treatment of Anterior Open Bite Using the Rapid Molar Intruder
NA
Completed
40 participants
Started: Sep 25, 2013 · Completed: Jan 20, 2015
1 condition
1 sponsor
1 location
NCT01782131
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
PHASE3
Completed
585 participants
Started: Sep 25, 2013 · Completed: Sep 10, 2019
2 conditions
1 sponsor
0 locations
NCT04335045
Phase I Study of PH100 (Ecklonia Cava Phlorotannins)
PHASE1
Completed
48 participants
Started: Sep 25, 2013 · Completed: Dec 8, 2014
1 condition
2 sponsors
1 location
NCT01910051
Explorative Assessment of Biomarkers in Overweight and Obese Subjects
N/A
Completed
106 participants
Started: Sep 25, 2013 · Completed: Dec 23, 2021
1 condition
1 sponsor
1 location
NCT01959490
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
PHASE2
Completed
16 participants
Started: Sep 24, 2013 · Completed: Mar 29, 2017
4 conditions
2 sponsors
1 location
NCT01949506
(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas
NA
Completed
9 participants
Started: Sep 24, 2013 · Completed: Oct 4, 2019
2 conditions
1 sponsor
1 location
NCT01935336
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
PHASE2
Completed
171 participants
Started: Sep 24, 2013 · Completed: Nov 30, 2017
8 conditions
2 sponsors
1 location
NCT01964287
First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.
PHASE1/PHASE2
Completed
78 participants
Started: Sep 24, 2013 · Completed: Dec 30, 2020
1 condition
1 sponsor
1 location
NCT03391024
Non-Contact Intraoperative Optical Imaging During Instrumentation Procedure
NA
Completed
40 participants
Started: Sep 24, 2013 · Completed: Aug 1, 2015
1 condition
1 sponsor
1 location
NCT01948739
Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke
NA
Completed
18 participants
Started: Sep 24, 2013 · Completed: Apr 28, 2018
2 conditions
5 sponsors
1 location
NCT01962441
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
PHASE3
Completed
601 participants
Started: Sep 24, 2013 · Completed: Jul 7, 2016
1 condition
1 sponsor
78 locations
NCT01879085
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
PHASE1/PHASE2
Completed
37 participants
Started: Sep 24, 2013 · Completed: Apr 15, 2021
1 condition
2 sponsors
1 location
NCT01965652
Long Term Safety of Naldemedine
PHASE3
Completed
1,246 participants
Started: Sep 24, 2013 · Completed: Jan 12, 2016
1 condition
1 sponsor
186 locations
NCT01921140
To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours
PHASE1
Completed
60 participants
Started: Sep 24, 2013 · Completed: Mar 15, 2022
1 condition
1 sponsor
12 locations
NCT02785926
Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates
N/A
Completed
53 participants
Started: Sep 24, 2013 · Completed: Oct 22, 2018
1 condition
1 sponsor
1 location
Previous
1
More pages
3551
3552
3553
3554
3555
3556
3557
More pages
6093
Next